Medical Toxicology Commons^™

The Effects Of Paclitaxel On Cellular Migration And The Cytoskeleton, Ashley Salguero-Gonzalez

Thinking Matters Symposium

In a clinical setting, some patients are exposed to an anti-cancer chemotherapy agent, paclitaxel. Cancerous cells undergo rapid, continuous cell division without control. Chemotherapy treatments try to slow and stop the uncontrollable cell division cycles and eliminate cancerous cells in the process. Paclitaxel serves as a treatment for some types of cancers, including lung, melanoma, bladder, and esophageal. Because it targets the cytoskeleton, paclitaxel can also influence cell migration. This project utilizes a cellular migration assay and an immunohistochemistry assay to analyze the effects of paclitaxel on the movement of cells and on the cytoskeleton of neuroglia rat cells with …

Investigating The Effect Of Arsenic On Chromium(Vi)-Induced Genotoxicity In Human Lung Fibroblasts, Jason Stewart Ms

All Student Scholarship

Hexavalent chromium (Cr(VI)) compounds are well-established human lung carcinogens. Arsenic (As) is a well documented human carcinogen with long term exposure to AS in drinking water being linked to lung, kidney and liver cancer, among others. Co-exposure studies are now becoming more common as humans are not exposed to just one toxicant at a time. This is the first study to investigate the effects of co-exposure with arsenic and soluble or particulate Cr(Vi) compounds in human lung fibroblasts.

Policy For Identifying And Assessing The Health Risks Of Toxic Substances, Maine Bureau Of Health

Maine Collection

Policy for Identifying and Assessing the Health Risks of Toxic Substances

by Norman T. Anderson, Environmental Toxicology Program, Division of Disease Control, Bureau of Health (February, 1988).

Contents: Section I: Introduction / Section II: Methods / Section III: Exposure Assessment / Section IV: Hazard Identification / Section V: Hazard Assessment / Section VI: Risk Characterization / List of Figures / List of Tables